Study search
Go straight to the source
Search PubMed, Europe PMC and ClinicalTrials.gov from one box. Results come from the indexes themselves, newest first, each linked to its original record.
Amiravo's reviewed summary: Exenatide research reference →
2,877 records · showing 25 · open this search in PubMed
- PubMedImpact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis.Digestive diseases and sciences · 2026 Nov
- PubMedSystematic ReviewMeta-AnalysisEffects of glucagon-like peptide-1 receptor agonists on metabolic outcomes in antipsychotic-treated patients with schizophrenia: A systematic review and meta-analysis.Schizophrenia research · 2026 Nov
- PubMedSystematic ReviewSkeletal effects of GLP-1 receptor agonist therapy in adults with overweight or obesity: a systematic review.Archives of osteoporosis · 2026 Oct 23
- PubMedReviewGLP-1 and Alcohol-Related Behaviors: Insights From Preclinical Studies.Biological psychiatry · 2026 Oct 15
- PubMedSystematic ReviewReviewEffects of glucagon-like peptide-1 (GLP-1) mono-agonists on reward processing in animal models: a systematic review.Acta neuropsychiatrica · 2026 Oct 14
- PubMedEfficacy of low-dose pioglitazone in combination with exenatide on glucose control in patients with T2DM.BMJ open diabetes research & care · 2026 Oct 13
- PubMedAudiovestibular adverse event reporting profiles of GLP-1 receptor agonists: A case-case pharmacovigilance study using FDA AEMS data.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026 Oct 13
- PubMedReviewThe therapeutic potential of GLP-1 receptor agonists in central nervous system diseases: immune cell modulation and neuroinflammation.Expert review of clinical immunology · 2026 Oct 13
- PubMedDevelopment and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application.Journal of chromatography. A · 2026 Oct 11
- PubMedThe Effect of Exanatide on Recovery of the Facial Nerve Crush Injury in the Rat.The journal of international advanced otology · 2026 Oct 9
- PubMedDevelopment and validation of qualitative methods for the detection of GLP-1 receptor agonists in serum and dried blood spots by LC-HRMS/MS for doping control purposes.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2026 Oct 8
- PubMedGLP-1 Receptor Agonists Are Associated With Lower Early Revision Risk Compared to Bariatric Surgery Following Total Hip Arthroplasty: A Retrospective Cohort Study.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2026 Oct 7
- PubMedEditorialCommentReply: Genetically proxied GLP1R expression does not predict exenatide response in the Exenatide-PD3 trial.Brain : a journal of neurology · 2026 Oct 5
- PubMedEditorialCommentGenetically proxied GLP1R expression does not predict exenatide response in the Exenatide-PD3 trial.Brain : a journal of neurology · 2026 Oct 5
- PubMedGlucagon-like peptide-1 receptor agonists in hidradenitis suppurativa: A nationwide cohort study.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 Oct 3
- PubMedEditorialWhen weight-loss drugs reduce drinking: glucagon-like peptide-1 receptor agonists as phenotype-enriched harm-reduction therapy for alcohol use disorder.Annals of medicine and surgery (2012) · 2026 Oct
- PubMedGut-kidney signaling is impaired in individuals with type 2 diabetes.Clinical kidney journal · 2026 Oct
- PubMedTirzepatide safety in EudraVigilance: descriptive and disproportionality analysis of preferred terms related to suboptimal treatment outcomes and drug-use-related issues.BMJ open · 2026 Oct 1
- PubMedGlucagon-like peptide-1 receptor agonists in psoriasis management.Clinics in dermatology · 2026 Oct 1
- PubMedModulation of Endoplasmic Reticulum Stress via CEBPB: A Potential Molecular Link to Therapeutic Action in Substance Use Disorders.CNS neuroscience & therapeutics · 2026 Oct
- PubMedSystematic ReviewMeta-AnalysisGLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.Drugs · 2026 Oct
- PubMedRandomized Controlled TrialGlucose-lowering in type 2 diabetes may be mediated by improved proinsulin processing without better β-cell compensation.American journal of physiology. Endocrinology and metabolism · 2026 Oct 1
- PubMedPrescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions.Clinical pharmacology and therapeutics · 2026 Oct
- PubMedObservational StudySemaglutide and Neovascular Age-Related Macular Degeneration among Adults with Type 2 Diabetes: An Observational Health Data Sciences and Informatics Network Study.Ophthalmology · 2026 Oct
- PubMedAcute glucagon-like peptide-1 receptor agonist, semaglutide, attenuates cue-, drug-, and stress-induced fentanyl seeking in male Sprague-Dawley rats.Behavioural pharmacology · 2026 Oct 1
Queries go directly from your browser to NCBI, EMBL-EBI and ClinicalTrials.gov; Amiravo does not store them. Study-type labels come from the indexes and can be wrong. A record's presence says nothing about whether a compound works or is safe. PubMed data via NCBI E-utilities; see NCBI policies.